Is the active ingredient in the medication.
Cilostazol is primarily prescribed for the treatment of intermittent claudication, a condition causing pain in the legs during physical activity due to poor blood flow.
It may also be used to prevent blood clots from forming in the arteries after a heart attack or angioplasty.
Cilostazol Tablets Ip 50mg (Cilostazol) works by relaxing and widening the blood vessels, improving blood flow to the legs and reducing pain associated with intermittent claudication. It also inhibits platelet aggregation, preventing blood clots from forming.
Store cilostazol at room temperature, away from moisture and heat. Keep it out of reach of children and pets. Do not use if the packaging is damaged or tampered with.
The dosage and frequency of cilostazol will vary depending on the individual patient's condition and response to treatment.
It is typically taken orally, twice a day, with or without food.
Follow your doctor's instructions carefully.
Do not change the dosage or stop taking the medication without consulting your doctor.
Less common side effects may include bleeding, bruising, shortness of breath, and allergic reactions.
Common side effects of cilostazol include headache, diarrhea, nausea, dizziness, and stomach pain.
It is generally advised to limit alcohol consumption while taking cilostazol, as it can increase the risk of bleeding.
Cilostazol can cause dizziness, so it is advisable to avoid driving or operating machinery until you know how it affects you.
Cilostazol should not be taken during pregnancy unless the potential benefits outweigh the risks. It is also not recommended for breastfeeding mothers.
Cilostazol is not typically prescribed for children.
People with kidney problems may need to adjust the dosage of cilostazol, and it may not be appropriate for those with severe kidney disease.
Cilostazol should be used with caution in patients with liver problems.
FDA Drug Information: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-cilostazol-pletal-increased-risk-bleeding-patients-receiving-certain
Mayo Clinic: https://www.mayoclinic.org/diseases-conditions/intermittent-claudication/symptoms-causes/syc-20353076
National Institutes of Health: https://www.ncbi.nlm.nih.gov/pubmed/12511455
